AAAAAA

   
Results: 1-8 |
Results: 8
A PHASE-II STUDY OF DOCETAXEL AND CISPLATIN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCN)
Authors: FORASTIERE A GLISSON B MURPHY B FRENETTE G OCONNELL B
Citation: A. Forastiere et al., A PHASE-II STUDY OF DOCETAXEL AND CISPLATIN IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCN), Annals of oncology, 9, 1998, pp. 361-361
PHASE-I STUDY OF CONCOMITANT CHEMORADIOTHERAPY WITH PACLITAXEL, FLUOROURACIL, AND HYDROXYUREA WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR PATIENTS WITH POOR-PROGNOSIS CANCER OF THE HEAD AND NECK
Authors: BROCKSTEIN B HARAF DJ STENSON K FASANMADE A STUPP R GLISSON B LIPPMAN SM RATAIN MJ SULZEN L KLEPSCH A WEICHSELBAUM RR VOKES EE
Citation: B. Brockstein et al., PHASE-I STUDY OF CONCOMITANT CHEMORADIOTHERAPY WITH PACLITAXEL, FLUOROURACIL, AND HYDROXYUREA WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR PATIENTS WITH POOR-PROGNOSIS CANCER OF THE HEAD AND NECK, Journal of clinical oncology, 16(2), 1998, pp. 735-744
INTEGRATION OF FILGRASTIM INTO CHEMORADIATION FOR LIMITED SMALL-CELL LUNG-CANCER - A PHASE-I STUDY
Authors: GLISSON B KOMAKI R LEE JS SHIN DM FOSSELLA F MURPHY WK KURIE J PEREZSOLER R SCHEA R VADHANRAJ S
Citation: B. Glisson et al., INTEGRATION OF FILGRASTIM INTO CHEMORADIATION FOR LIMITED SMALL-CELL LUNG-CANCER - A PHASE-I STUDY, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 331-336
CISPLATIN, IFOSFAMIDE, AND PROLONGED ORAL ETOPOSIDE IN THE TREATMENT OF PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CARCINOMA
Authors: GLISSON B LEE JS PALMER J FOSSELLA F SHIN DM MURPHY WK PEREZSOLER R HONG WK
Citation: B. Glisson et al., CISPLATIN, IFOSFAMIDE, AND PROLONGED ORAL ETOPOSIDE IN THE TREATMENT OF PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CARCINOMA, Cancer, 82(2), 1998, pp. 301-308
MAXIMUM-TOLERATED DOSE DEFINED FOR SINGLE-AGENT GEMCITABINE - A PHASE-I DOSE-ESCALATION STUDY IN CHEMOTHERAPY-NAIVE PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: FOSSELLA FV LIPPMAN SM SHIN DM TARASSOFF P CALAYAGJUNG M PEREZSOLER R LEE JS MURPHY WK GLISSON B RIVERA E HONG WK
Citation: Fv. Fossella et al., MAXIMUM-TOLERATED DOSE DEFINED FOR SINGLE-AGENT GEMCITABINE - A PHASE-I DOSE-ESCALATION STUDY IN CHEMOTHERAPY-NAIVE PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 15(1), 1997, pp. 310-316
PHASE-II STUDY OF DOCETAXEL FOR ADVANCED OR METASTATIC PLATINUM-REFRACTORY NON-SMALL-CELL LUNG-CANCER
Authors: FOSSELLA FV LEE JS SHIN DM CALAYAG M HUBER M PEREZSOLER R MURPHY WK LIPPMAN S BENNER S GLISSON B CHASEN M HONG WK RABER M
Citation: Fv. Fossella et al., PHASE-II STUDY OF DOCETAXEL FOR ADVANCED OR METASTATIC PLATINUM-REFRACTORY NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 13(3), 1995, pp. 645-651
PHASE-II STUDY OF DOCETAXEL FOR RECURRENT OR METASTATIC NON-SMALL-CELL LUNG-CANCER
Authors: FOSSELLA FV LEE JS MURPHY WK LIPPMAN SM CALAYAG M PANG A CHASEN M SHIN DM GLISSON B BENNER S HUBER M PEREZSOLER R HONG WK RABER M
Citation: Fv. Fossella et al., PHASE-II STUDY OF DOCETAXEL FOR RECURRENT OR METASTATIC NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(6), 1994, pp. 1238-1244
INTERDIGITATING VERSUS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER (SCLC)
Authors: KOMAKI R SHIN D GLISSON B FOSSELLA F MURPHY W GARDEN A OSWALD M HONG W ROTH J PETERS L ELLERBROEK N
Citation: R. Komaki et al., INTERDIGITATING VERSUS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER (SCLC), International journal of radiation oncology, biology, physics, 27, 1993, pp. 188-188
Risultati: 1-8 |